查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924729

外周支撑导管导引线市场按类型、材质、涂层、尖端、应用和最终用户划分 - 全球预测 2026-2032

Peripheral Supportive Guide Wire Market by Type, Material, Coating, Tip Configuration, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年外周支撑导管导引线市场价值为 5.6677 亿美元，预计到 2026 年将增长至 6.3361 亿美元，预计到 2032 年将达到 12.6271 亿美元，复合年增长率为 12.12%。

关键市场统计数据
基准年 2025 5.6677亿美元
预计年份：2026年 6.3361亿美元
预测年份 2032 12.6271亿美元
复合年增长率 (%) 12.12%

对影响现代血管内手术中周边导管导引线使用的技术、临床和商业性环境进行权威深入的剖析。

週边血管支撑导管导引线已发展成为日益广泛的血管内手术中不可或缺的组成部分，是器械输送、病变穿刺和治疗性介入的基础通道。这些器械融合了机械性能、材料科学和先进设计，以满足心血管、神经血管和周边介入治疗中多样化的临床需求。临床医生优先考虑易用性、触觉回馈和非侵入性，而医院采购部门和门诊中心则考虑灭菌相容性、供应连续性和生命週期成本。

临床预期、材料创新和供应链永续性的融合如何重塑导管导引线研发的产品策略和竞争优势

由于临床需求、材料创新和医疗服务体系重组的融合，週边血管支撑导管导引线的市场格局正在转变。微创手术需求的不断增长，使得导丝的操控性和扭矩传递性能备受重视，促使研发人员不断改进导丝核心设计，并开发多样化的尖端几何形状，以应对复杂的血管解剖结构。同时，混合手术和影像引导介入的兴起，也提升了在多种影像模式下均能展现可预测性能的导丝的价值。

对 2025 年关税调整如何改变导管导引线产业的到岸成本、筹资策略、购买行为和供应商韧性进行全面评估。

2025年的关税调整和贸易政策转变对外围支撑导管导引线系统产生了累积影响，导致到岸成本上升、采购管道变更以及供应商多元化进程加快。拥有全球製造地的製造商正在重新评估其零件采购，优化材料清单结构以降低关税风险，并整合供应商关係以确保交货可靠性。这些措施也促使原始设备製造商 (OEM) 和契约製造製造商之间就长期产能和成本分摊机制展开活性化谈判。

利用多层次细分框架，将临床应用、设备类型、材料、涂层、先进结构和最终用户工作流程连结起来，制定精准的产品和商业策略。

细分市场分析揭示了不同的效能预期和应用路径，这些都为产品设计和市场推广策略提供了基础。依应用领域划分，导管导引线市场涵盖心血管、神经血管和周边血管领域，其中心血管领域可进一步细分为冠状动脉介入治疗和周边心血管手术。神经血管应用领域则因动脉瘤栓塞和中风介入治疗的需求而有所差异，而周边血管应用领域则包括颈动脉、下肢和肾血管介入治疗。这些临床应用领域对导丝尖端柔软性、推送性和扭矩控制等属性提出了不同的要求，因此难以采用「一刀切」的策略来满足所有手术领域的临床需求。

美洲、欧洲、中东和非洲以及亚太地区的临床实践、监管差异和供应链现状将如何决定不同的商业化和推广路径？

区域趋势对关键地区的市场进入、临床合作和供应链发展提出了不同的要求。在美洲，心血管和周边介入手术量庞大，大型医院系统实力雄厚，竞争格局以差异化的临床结果和服务模式为核心，这些因素共同塑造了采购趋势。因此，供应商往往优先考虑参与临床试验和获得医院外科医生的支持，以推动产品应用。

竞争定位和能力丛集评估重点关注临床差异化、材料技术领先地位以及供应链策略，这些因素共同推动了导管导引线产品系列的持续领先地位。

导管导引线领域的竞争格局正在发生变化，老牌医疗设备製造商和新兴专业公司在临床差异化、材料科学技术和供应可靠性方面竞争。拥有整合研发能力和临床支援计画的公司在产生医院广泛采用所需的临床证据方面具有优势。同时，提供客製化培训、快速回应的技术支援以及符合医院库存管理实务的供应协议的製造商，能够加强与终端用户的长期合作关係。

整合材料创新、临床证据、供应链韧性和商业模式的实用策略重点，以在不同的医疗保健服务环境中实现持续的偏好。

产业领导者应采取多管齐下的策略，整合产品创新、临床证据产生和稳健的供应链。首先，应优先开发平台，其设计特性应直接满足上述差异化的临床需求，并确保材料选择、涂层化学性质和尖端几何形状均通过针对特定手术的台架测试和临床医生主导的可用性研究检验。其次，需要投资于有针对性的临床项目，以证明手术效率、安全性结果以及与配套器械整合的益处。这些计画应透过同侪审查的临床论坛进行推广，并与产业领导者合作。

采用严谨的混合方法调查方法，结合临床医生访谈、监管审查、供应链分析和证据综合，以获得可操作的医疗器材和商业性洞察。

我们的研究途径结合了定性和定量方法，旨在获得具有临床意义和可操作性的见解。我们透过对介入性心臟病专家、介入神经放射学、血管外科医生、采购主管和供应链主管进行结构化访谈，收集了关键信息，以获取关于设备性能、采购因素和临床工作流程整合的第一手意见。此外，我们也咨询了监管和灭菌专家，以补充这些访谈，以便更好地理解开发和合规方面的考量。

一项全面的分析，旨在明确在医疗保健机构中实现持续应用所需的技术、临床和营运方面的必要条件。

累积分析表明，外周支撑导管导引线领域的成功取决于将设备特性与特定临床应用紧密匹配，同时建立稳健的商业和供应模式。材料和涂层创新、精密的尖端几何形状以及针对特定手术的检验是临床应用的核心，但这些技术优势必须与采购部门和临床管理团队所重视的、可证明的营运效益相结合。区域市场动态要求采取适应性策略，充分考虑不同的法规结构、医院类型和临床医生培训路径。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 外周支撑导管导引线市场（按类型划分）

  • 亲水性
  • 非亲水性

9. 外周支撑导管导引线市场（依材质划分）

  • 镍钛诺
  • 不銹钢

10. 外周支撑导管导引线市场（依涂层分类）

  • 亲水性
  • PTFE
  • 硅酮

第十一章 依尖端形状分類的外周支撑导管导引线市场

  • 角度
  • J形尖端
  • 直的

第十二章 外围支撑导管导引线市场（依应用领域划分）

  • 心血管系统
    • 冠状动脉
    • 週边心血管系统
  • 神经血管
    • 动脉瘤栓塞术
    • 中风治疗
  • 週边血管
    • 颈动脉血管
    • 下肢
    • 肾臟血管

第十三章 外围支撑导管导引线市场（依最终用户划分）

  • 门诊手术中心
    • 循环系统中心
    • 週边血管中心
  • 医院
  • 专科诊所

14. 週边支撑导管导引线市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 週边支撑导管导引线市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国外周支撑导管导引线市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国週边设备支援导管导引线市场

第十八章：中国週边支撑导管导引线市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Cordis Corporation
  • Galt Medical Corp.
  • Integer Holdings Corporation
  • Medtronic plc
  • Meril Life Sciences Private Limited
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vascular Solutions, Inc.
Product Code: MRR-7A380DA7C45B

The Peripheral Supportive Guide Wire Market was valued at USD 566.77 million in 2025 and is projected to grow to USD 633.61 million in 2026, with a CAGR of 12.12%, reaching USD 1,262.71 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 566.77 million
Estimated Year [2026] USD 633.61 million
Forecast Year [2032] USD 1,262.71 million
CAGR (%) 12.12%

An authoritative orientation to the technological, clinical, and commercial landscape shaping peripheral supportive guide wire use across contemporary endovascular practice

Peripheral supportive guide wires have evolved into indispensable components across a growing range of endovascular procedures, serving as the foundational conduit for device delivery, lesion crossing, and therapeutic intervention. These devices combine mechanical performance, material science, and tip engineering to meet diverse clinical demands in cardiovascular, neurovascular, and peripheral vascular interventions. Clinicians prioritize navigability, tactile feedback, and atraumatic behavior, while hospital procurement and ambulatory centers weigh sterilization compatibility, supply continuity, and lifecycle costs.

Over the past decade, iterative improvements in nitinol metallurgy, coating chemistry, and tip configurations have enabled clinicians to address increasingly complex anatomies with confidence. As procedural volumes rise and interventional techniques diversify, guide wires have become central to multidisciplinary pathways that span coronary revascularization, cerebrovascular interventions, and lower-extremity revascularization. Consequently, product development has shifted toward purpose-driven portfolios that emphasize specific clinical applications, end-user workflows, and compatibility with emerging catheter and device platforms.

Transitioning from legacy stainless steel constructions to more advanced materials has broadened the performance envelope, while regulatory scrutiny and reimbursement dynamics continue to shape adoption timelines. In this context, stakeholders require concise, clinically grounded intelligence to prioritize R&D investment, refine supply chain strategies, and align commercialization efforts with evolving procedural standards.

How converging clinical expectations, material innovation, and supply resilience are reshaping product strategy and competitive advantage in guide wire development

The landscape for peripheral supportive guide wires is undergoing transformative shifts driven by converging clinical demands, material innovation, and care delivery reconfiguration. Minimally invasive expectations have increased the premium on enhanced steerability and torque transmission, prompting developers to refine core design attributes and expand tip geometries to match complex vessel anatomies. In parallel, the diffusion of hybrid procedures and the rise of image-guided interventions have increased the value of wires that offer predictable behavior under diverse imaging modalities.

Supply chain restructuring and nearshoring trends have influenced sourcing strategies for raw materials such as nitinol and specialty coatings, elevating resilience as a board-level priority. Regulatory pathways have also become more exacting, with increased emphasis on biocompatibility and sterilization validation that affect development timelines. Clinician preferences are shifting as well; multidisciplinary teams now demand devices that integrate seamlessly with a growing array of catheters, sheaths, and embolic systems, which is driving tighter collaboration between device makers and clinical research networks.

Taken together, these dynamics are fostering a market environment where incremental innovation is supplemented by targeted platform strategies aimed at specific clinical subspecialties. As a result, companies that can demonstrate clear clinical differentiation, robust quality systems, and responsive supply models are positioned to capture preference among clinicians and procurement stakeholders alike.

An integrated assessment of how 2025 tariff adjustments are altering landed costs, sourcing strategies, procurement behavior, and supplier resilience across the guide wire ecosystem

Recent tariff adjustments and trade policy shifts introduced in 2025 have had a cumulative impact on the peripheral supportive guide wire ecosystem by increasing landed costs, prompting sourcing realignments, and accelerating supplier diversification. Manufacturers with global manufacturing footprints have responded by reassessing component sourcing, optimizing bill-of-materials compositions to reduce tariff exposure, and consolidating supplier relationships to preserve delivery reliability. These measures have also intensified negotiations between OEMs and contract manufacturers regarding long-term capacity commitments and cost-sharing mechanisms.

Procurement teams within hospitals and ambulatory surgical centers are adapting by expanding supplier qualification protocols and by seeking transparency around total cost of ownership rather than unit price alone. In addition, distributors and group purchasing organizations have adjusted inventory policies to mitigate short-term volatility, emphasizing buffer stocks for high-use items while collaborating on logistic efficiencies.

Clinically, the ripple effects have been more operational than procedural; where hospitals face higher acquisition costs, prioritization frameworks have shifted toward devices that deliver demonstrable procedural efficiencies or reduce downstream resource consumption. From a strategic perspective, companies able to evidence resilient regional supply chains, local value-add, and clear regulatory compliance have a competitive edge in negotiating long-term contracts in this new tariff environment.

A layered segmentation framework connecting clinical applications, device types, materials, coatings, tip architectures, and end-user workflows to inform precise product and commercial strategies

Segmentation intelligence reveals differentiated performance expectations and adoption pathways that inform both product design and go-to-market approaches. Based on application, the guide wire landscape spans cardiovascular, neurovascular, and peripheral vascular uses, with cardiovascular requirements further refined across coronary artery interventions and peripheral cardiovascular procedures; neurovascular applications are distinguished between aneurysm coiling and stroke intervention needs; and peripheral vascular use cases encompass carotid vascular, lower extremity, and renal vascular interventions. These clinical subdivisions impose distinct demands on attributes such as tip flexibility, pushability, and torque control, meaning that a one-size-fits-all strategy is unlikely to achieve clinical preference across all procedural domains.

Based on type, products are categorized as hydrophilic or non-hydrophilic, a classification that directly influences navigation performance, lubricity, and operator handling under various procedural conditions. Based on material, nitinol and stainless steel represent two material classes with differing trade-offs between superelasticity, memory, and radiopacity; choosing between them is a function of the targeted vessel tortuosity and clinical endpoint. Based on coating, hydrophilic, PTFE, and silicone coatings each deliver discrete surface interactions with vessel walls and catheter assemblies, shaping clinical selection for specific lesion types and imaging environments. Based on tip configuration, angled, J-tip, and straight tip designs support different crossing strategies and vessel engagement techniques, with tip choice often dictated by the lesion morphology and access strategy.

Based on end user, commercial strategies must reflect the distinct purchasing and clinical workflows of ambulatory surgical centers, hospitals, and specialty clinics. Ambulatory surgical centers include dedicated cardiovascular centers and peripheral centers that favor throughput and disposables models, while hospital segments include community hospitals and tertiary care hospitals where preference may be driven by complex-case performance and integration with advanced imaging suites. Recognizing these layered segmentations enables a granular approach to portfolio planning, clinical evidence generation, and targeted value propositions for each buyer archetype.

How regional clinical practices, regulatory nuance, and supply chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific determine differentiated commercialization and adoption pathways

Regional dynamics create distinct imperatives for market entry, clinical engagement, and supply chain architecture across major geographies. In the Americas, purchasing tendencies are shaped by high procedural volumes in advanced cardiovascular and peripheral interventions, a strong presence of large hospital systems, and a competitive supplier landscape that rewards differentiation in clinical outcomes and service models. As a consequence, vendors often prioritize clinical trial engagement and hospital-based surgeon advocacy to drive adoption.

In Europe, Middle East & Africa, variability in regulatory frameworks and heterogeneous procurement practices require adaptable market access approaches. Reimbursement nuance and national purchasing protocols create opportunities for regionally tailored product variants and localized technical support. Manufacturers that invest in regional regulatory expertise and distributor relationships can accelerate adoption by aligning product claims with jurisdictional requirements.

In Asia-Pacific, rapid expansion of interventional capacity, diverse hospital archetypes, and a growing preference for high-performance devices are reshaping demand patterns. Local manufacturing partnerships and regional clinical training programs are proving effective in building clinician trust and addressing logistical constraints. Across all regions, a common thread is the increasing emphasis on supply chain resilience, localized regulatory alignment, and clinician education to support safe and effective device utilization.

An evaluation of competitive positioning and capability clusters that highlight clinical differentiation, materials leadership, and supply chain strategies driving sustained preference in guide wire portfolios

Competitive dynamics in the guide wire segment are evolving as established device manufacturers and emerging specialized firms compete on clinical differentiation, material science expertise, and supply reliability. Companies with integrated R&D capabilities and clinical advocacy programs have an advantage in generating the procedural evidence required for broad hospital adoption. Meanwhile, manufacturers that offer tailored training, rapid technical support, and supply agreements that align with hospital inventory practices strengthen long-term relationships with end users.

In addition, specialist developers focusing on coatings chemistry, tip innovation, or niche clinical applications are influencing overall product expectations by introducing targeted solutions that address specific procedural pain points. Strategic partnerships between device makers and contract manufacturing organizations are becoming more prevalent, enabling flexible manufacturing scale-up while preserving product quality. Distribution strategies likewise vary, with some companies opting for direct hospital engagement and clinical education, and others working through regional distributors to extend reach into varied healthcare settings.

Ultimately, competitive advantage accrues to organizations that can demonstrate a clear clinical value proposition, robust quality and regulatory systems, and adaptable supply models that mitigate disruption while supporting clinician adoption and procurement requirements.

Actionable strategic priorities to align material innovation, clinical evidence, supply resilience, and commercial models for sustained preference across diverse healthcare delivery settings

Industry leaders should pursue a multi-dimensional strategy that aligns product innovation, clinical evidence generation, and resilient supply operations. First, prioritize platform development that maps design attributes directly to the segmented clinical needs described earlier, ensuring that material selection, coating chemistry, and tip configuration are validated through procedure-specific bench testing and clinician-led usability studies. Second, invest in targeted clinical programs that demonstrate procedural efficiency, safety outcomes, and integration benefits with complementary devices; these programs should be designed for dissemination through peer-reviewed clinical forums and key opinion leader engagement.

Third, strengthen supply chain resilience by diversifying qualified suppliers, exploring regional manufacturing options, and incorporating tariff exposure into procurement contracts. Fourth, align commercial models to the end-user landscape by creating differentiated value propositions for ambulatory surgical centers, community hospitals, tertiary care centers, and specialty clinics, offering tailored training, bundled service offerings, and inventory management solutions that reduce administrative burden. Fifth, accelerate regulatory readiness by building cross-functional teams that can anticipate jurisdictional requirements, streamline submission packages, and ensure post-market surveillance is both rigorous and transparent.

By executing these priorities in parallel and measuring progress through operational and clinical KPIs, organizations can both mitigate near-term headwinds and position themselves for sustained preference among clinicians and procurement stakeholders.

A rigorous mixed-methods research framework combining clinician interviews, regulatory review, supply chain mapping, and evidence synthesis to produce actionable device and commercial insights

The research approach combined qualitative and quantitative techniques to produce clinically relevant, operationally actionable insights. Primary input was gathered through structured interviews with interventional cardiologists, neurointerventional specialists, vascular surgeons, procurement leaders, and supply chain executives to capture firsthand perspectives on device performance, purchasing drivers, and clinical workflow integration. These interviews were complemented by advisory consultations with regulatory and sterilization experts to contextualize development and compliance considerations.

Secondary research included a structured review of peer-reviewed clinical literature, procedural guidelines, and publicly available regulatory documentation to validate clinical use-cases and to triangulate device attribute requirements. Supply chain mapping analyzed component sourcing, contract manufacturing relationships, and logistics pathways to identify potential points of vulnerability and resilience strategies. Finally, a synthesis phase translated technical findings into commercial implications, testing hypotheses against clinician priorities and procurement realities to ensure recommendations were both clinically credible and operationally feasible.

Throughout the process, quality controls included cross-validation of interview inputs, internal expert review of clinical inferences, and iterative refinement of conclusions to ensure clarity, relevance, and applicability for strategy and product development stakeholders.

A consolidated synthesis identifying the essential technical, clinical, and operational imperatives required to translate product capability into sustained adoption across healthcare settings

The cumulative analysis highlights that success in the peripheral supportive guide wire domain hinges on tightly aligning device attributes to specific clinical applications while simultaneously building resilient commercial and supply models. Material and coating innovations, refined tip geometries, and procedure-specific validation are central to clinical adoption, but these technical strengths must be paired with demonstrable operational benefits that matter to procurement and clinical governance teams. Regional market dynamics demand adaptive approaches that account for differing regulatory frameworks, hospital archetypes, and clinician training pathways.

Moreover, recent trade policy adjustments have underscored the need for strategic supply chain planning, encouraging manufacturers to explore regional sourcing and manufacturing partnerships to maintain competitive cost structures and secure delivery timelines. Competitive differentiation will increasingly depend on the ability to offer integrated solutions that combine performance, evidence, and service models tailored to the needs of ambulatory surgical centers, community and tertiary hospitals, and specialty clinics.

Collectively, these insights suggest a path forward for organizations seeking to convert technical capability into durable market preference: prioritize application-led design, invest in high-quality clinical validation, and build supply chains and commercial models that are both resilient and responsive to end-user needs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Supportive Guide Wire Market, by Type

  • 8.1. Hydrophilic
  • 8.2. Non-Hydrophilic

9. Peripheral Supportive Guide Wire Market, by Material

  • 9.1. Nitinol
  • 9.2. Stainless Steel

10. Peripheral Supportive Guide Wire Market, by Coating

  • 10.1. Hydrophilic
  • 10.2. PTFE
  • 10.3. Silicone

11. Peripheral Supportive Guide Wire Market, by Tip Configuration

  • 11.1. Angled
  • 11.2. J-Tip
  • 11.3. Straight

12. Peripheral Supportive Guide Wire Market, by Application

  • 12.1. Cardiovascular
    • 12.1.1. Coronary Artery
    • 12.1.2. Peripheral Cardiovascular
  • 12.2. Neurovascular
    • 12.2.1. Aneurysm Coiling
    • 12.2.2. Stroke Intervention
  • 12.3. Peripheral Vascular
    • 12.3.1. Carotid Vascular
    • 12.3.2. Lower Extremity
    • 12.3.3. Renal Vascular

13. Peripheral Supportive Guide Wire Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Cardiovascular Centers
    • 13.1.2. Peripheral Centers
  • 13.2. Hospitals
  • 13.3. Specialty Clinics

14. Peripheral Supportive Guide Wire Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Peripheral Supportive Guide Wire Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Peripheral Supportive Guide Wire Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Peripheral Supportive Guide Wire Market

18. China Peripheral Supportive Guide Wire Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. AngioDynamics, Inc.
  • 19.7. Asahi Intecc Co., Ltd.
  • 19.8. B. Braun Melsungen AG
  • 19.9. Becton, Dickinson and Company
  • 19.10. BIOTRONIK SE & Co. KG
  • 19.11. Boston Scientific Corporation
  • 19.12. Cook Medical LLC
  • 19.13. Cordis Corporation
  • 19.14. Galt Medical Corp.
  • 19.15. Integer Holdings Corporation
  • 19.16. Medtronic plc
  • 19.17. Meril Life Sciences Private Limited
  • 19.18. Merit Medical Systems, Inc.
  • 19.19. MicroPort Scientific Corporation
  • 19.20. MicroVention, Inc.
  • 19.21. Stryker Corporation
  • 19.22. Teleflex Incorporated
  • 19.23. Terumo Corporation
  • 19.24. Vascular Solutions, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NON-HYDROPHILIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NON-HYDROPHILIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NON-HYDROPHILIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANGLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANGLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANGLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY J-TIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY J-TIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY J-TIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STRAIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STRAIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STRAIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CORONARY ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CORONARY ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CORONARY ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANEURYSM COILING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANEURYSM COILING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANEURYSM COILING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STROKE INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STROKE INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STROKE INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CAROTID VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CAROTID VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CAROTID VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY LOWER EXTREMITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY LOWER EXTREMITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY LOWER EXTREMITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY RENAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY RENAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY RENAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)